The biotech industry has been in focus over the past week with pipeline and regulatory updates. The development of vaccines for COVID-19 continues to be in the spotlight with new emerging variants. Collaborations were in focus too.
Recap of the Week’s Most Important Stories:
Updates From Moderna: Moderna, Inc. (MRNA Quick QuoteMRNA ) announced that the FDA has approved an update to the emergency use authorization (EUA) of its COVID-19 vaccine (mRNA-1273). The regulatory body has authorized a third dose for immunocompromised individuals 18 years of age or....More>>>